Antibiotics are commonly prescribed to young children to combat conditions such as ear infections and pneumonia. But the drugs may disrupt the digestive microbiome at a significant time in a child’s ...

Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

A research team led by Professor Tong Zhang from the Department of Civil Engineering of Faculty of Engineering at the ...

Merck & Co/MSD’s three-drug antibiotic Recarbrio has been recommended for approval in Europe for Gram-negative infections, but should be reserved for use in patients with limited treatment options.

The Dow Jones Industrial Average is declining Wednesday morning with shares of Amgen and Merck seeing the biggest losses for the price-weighted average. Supported by world-class markets data from ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

A recent study found that up to 90% of sepsis patients may be overtreated. The study, published April 15 in Clinical Infectious Diseases and led by researchers from Brigham’s Women’s Hospital and ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...